HU9204170D0 - Method for producing immuno reactive compounds - Google Patents

Method for producing immuno reactive compounds

Info

Publication number
HU9204170D0
HU9204170D0 HU9204170A HU417091A HU9204170D0 HU 9204170 D0 HU9204170 D0 HU 9204170D0 HU 9204170 A HU9204170 A HU 9204170A HU 417091 A HU417091 A HU 417091A HU 9204170 D0 HU9204170 D0 HU 9204170D0
Authority
HU
Hungary
Prior art keywords
reactive compounds
immuno reactive
producing immuno
producing
compounds
Prior art date
Application number
HU9204170A
Other languages
Hungarian (hu)
Other versions
HUT63343A (en
Inventor
Ebo Sybren Bos
Petrus Johannes Boon
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of HU9204170D0 publication Critical patent/HU9204170D0/en
Publication of HUT63343A publication Critical patent/HUT63343A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
HU9204170A 1990-07-03 1991-06-28 Process for producing immunereactive compounds HUT63343A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90201781 1990-07-03

Publications (2)

Publication Number Publication Date
HU9204170D0 true HU9204170D0 (en) 1993-04-28
HUT63343A HUT63343A (en) 1993-08-30

Family

ID=8205056

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9204170A HUT63343A (en) 1990-07-03 1991-06-28 Process for producing immunereactive compounds

Country Status (7)

Country Link
EP (1) EP0537222A1 (en)
JP (1) JPH05507924A (en)
KR (1) KR930701201A (en)
CA (1) CA2086531A1 (en)
FI (1) FI925804A0 (en)
HU (1) HUT63343A (en)
WO (1) WO1992000763A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824632D0 (en) * 1998-11-10 1999-01-06 Celltech Therapeutics Ltd Biological compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
CA1168150A (en) * 1981-12-18 1984-05-29 The Governors Of The University Of Alberta Targeting conjugates of albumin and therapeutic agents
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
EP0293524A1 (en) * 1987-06-02 1988-12-07 Vasocor Atherosclerotic plaque immunoassay
EP0295719A3 (en) * 1987-06-19 1989-12-20 The Agouron Institute The sm-d antigen, the cloning of the sm-d antigen and the detection of systemic lupus erythematosus by using the sm-d antigen
ATE82136T1 (en) * 1987-08-10 1992-11-15 Miles Inc PURIFIED IGM.
US4937183A (en) * 1988-02-03 1990-06-26 Cytogen Corporation Method for the preparation of antibody-fragment conjugates
JPH03503117A (en) * 1988-02-12 1991-07-18 ハイテク　レセプター　アーベー Immunoglobulin-binding substances, their subfragments, their production methods, reagent kits, and immunoglobulin-binding substances
US4983529A (en) * 1988-06-10 1991-01-08 Abbott Laboratories Immunoassay for HIV-I antigens using F(AB')2 fragments as probe
KR900005995A (en) * 1988-10-31 1990-05-07 우메모또 요시마사 Modified Interleukin-2 and Method of Making the Same
EP0465513A1 (en) * 1989-03-27 1992-01-15 Centocor, Inc. FORMULATIONS FOR STABILIZING OF IgM ANTIBODIES

Also Published As

Publication number Publication date
FI925804A (en) 1992-12-21
KR930701201A (en) 1993-06-11
JPH05507924A (en) 1993-11-11
FI925804A0 (en) 1992-12-21
CA2086531A1 (en) 1992-01-04
EP0537222A1 (en) 1993-04-21
WO1992000763A1 (en) 1992-01-23
HUT63343A (en) 1993-08-30

Similar Documents

Publication Publication Date Title
HU912820D0 (en) Method for producing 1-triptophane
HU912903D0 (en) Method for producing azocyclic compounds
HU9203847D0 (en) Method for producing hydroxi-piperidines alkoxi ones
ZA913779B (en) Method for synthesis
HU913836D0 (en) Method for producing alpha-oxoacetamide derivatives
HUT56825A (en) Process for producing substituted 2-chloropyridines
CS324791A3 (en) Process for preparing kerebastin
EP0476141A4 (en) Process for producing tuber
HU9301807D0 (en) Method for producing dinitro-toluols
EP0441214A3 (en) Process for producing fiber-rubber composite
HU911400D0 (en) Process for producing cephalosporines
HUT58785A (en) Process for producing hypoallergene moth-oils
EP0478066A3 (en) New process for making 3-oxo-4-aza-androst-1-ene 17beta-ketones
HUT59695A (en) Process for producing hydroxy-ethyl-amine- and norstai
HUT58699A (en) Process for producing 2-chloro-5-methyl-pyridine
HU9202250D0 (en) Method for producing lysosime dimers
EP0461597A3 (en) Method for preparing monohalogenosilanes
HU9202920D0 (en) Process for producing 1-hydroxyalkyl-5-nitroimidazoles
HU910578D0 (en) Process for producing 4-hydroxiphenethyl-alcohol
HU910745D0 (en) Process for producing 1-treonine
HUT60239A (en) Process for producing glian
HU9204170D0 (en) Method for producing immuno reactive compounds
EP0452960A3 (en) Method for preparing hexamethyl cyclotrisilazane
GB2267705B (en) Process for producing 2-alkyl-4-halo-5-formylimidazoles
HU913943D0 (en) Substituted dibenz-oxa-thiocinones and method for producing said compounds

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee